Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
4.870
+0.150 (3.18%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Profound Medical Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Profound Medical stock has a target of 12, which predicts an increase of 146.41% from the current stock price of 4.87.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jul 16, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for Profound Medical is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Hold → Strong Buy Upgrades $9 → $12 | Hold → Strong Buy | Upgrades | $9 → $12 | +146.41% | Jul 16, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $13 → $11 | Strong Buy | Maintains | $13 → $11 | +121.77% | Mar 11, 2024 |
| Stifel | Stifel | Hold Maintains $11 → $9 | Hold | Maintains | $11 → $9 | +84.80% | Mar 8, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $14 → $13 | Strong Buy | Maintains | $14 → $13 | +161.81% | Jan 4, 2024 |
| Stifel | Stifel | Hold Initiates $11 | Hold | Initiates | $11 | +125.87% | Nov 28, 2023 |
Financial Forecast
Revenue This Year
28.33M
from 10.68M
Increased by 165.23%
Revenue Next Year
55.79M
from 28.33M
Increased by 96.94%
EPS This Year
-1.12
from -1.12
EPS Next Year
-0.87
from -1.12
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 42.0M | 82.1M | 148.3M | ||
| Avg | 28.3M | 55.8M | 92.8M | ||
| Low | 16.1M | 32.3M | 56.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 293.3% | 189.9% | 165.8% | ||
| Avg | 165.2% | 96.9% | 66.3% | ||
| Low | 50.5% | 14.2% | 1.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.11 | -0.62 | -1.20 | ||
| Avg | -1.12 | -0.87 | -1.15 | ||
| Low | -1.14 | -1.12 | -1.12 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.